AngioDynamics (ANGO) Misses Q1 EPS by 4c, Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $5.78 -1.53%
Revenue Growth %: -18.2%
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -18.2%
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $82.58 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of $0.01-$0.06, versus the consensus of $0.02. AngioDynamics sees FY2023 revenue of $342-348 million, versus the consensus of $344 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
